565 related articles for article (PubMed ID: 15068900)
41. Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications.
Jelinek DF; Ahmann GJ; Greipp PR; Jalal SM; Westendorf JJ; Katzmann JA; Kyle RA; Lust JA
Cancer Res; 1993 Nov; 53(21):5320-7. PubMed ID: 8221668
[TBL] [Abstract][Full Text] [Related]
42. [Immunophenotypic characteristics of multiple myeloma cells].
Li JL; Liu YR; Chang Y; Fu JY; Chen SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):226-8. PubMed ID: 12513791
[TBL] [Abstract][Full Text] [Related]
43. CD38 low IgG-secreting cells are precursors of various CD38 high-expressing plasma cell populations.
Arce S; Luger E; Muehlinghaus G; Cassese G; Hauser A; Horst A; Lehnert K; Odendahl M; Hönemann D; Heller KD; Kleinschmidt H; Berek C; Dörner T; Krenn V; Hiepe F; Bargou R; Radbruch A; Manz RA
J Leukoc Biol; 2004 Jun; 75(6):1022-8. PubMed ID: 15020647
[TBL] [Abstract][Full Text] [Related]
44. Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.
Liu D; Lin P; Hu Y; Zhou Y; Tang G; Powers L; Medeiros LJ; Jorgensen JL; Wang SA
J Clin Pathol; 2012 Sep; 65(9):823-9. PubMed ID: 22685235
[TBL] [Abstract][Full Text] [Related]
45. Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients.
Cassel A; Leibovitz N; Hornstein L; Quitt M; Aghai E
Exp Hematol; 1990 Dec; 18(11):1171-3. PubMed ID: 2226677
[TBL] [Abstract][Full Text] [Related]
46. Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells.
Ak I; Aslan V; Vardareli E; Gülbaş Z
Ann Hematol; 2003 Feb; 82(2):88-92. PubMed ID: 12601486
[TBL] [Abstract][Full Text] [Related]
47. Expression of CD24 on CD19- CD79a+ early B-cell progenitors in human bone marrow.
Israel E; Kapelushnik J; Yermiahu T; Levi I; Yaniv I; Shpilberg O; Shubinsky G
Cell Immunol; 2005; 236(1-2):171-8. PubMed ID: 16181617
[TBL] [Abstract][Full Text] [Related]
48. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P
Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022
[TBL] [Abstract][Full Text] [Related]
49. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A
J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187
[TBL] [Abstract][Full Text] [Related]
50. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
Sezer O; Heider U; Zavrski I; Possinger K
Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
[TBL] [Abstract][Full Text] [Related]
51. CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients.
Hosen N; Matsuoka Y; Kishida S; Nakata J; Mizutani Y; Hasegawa K; Mugitani A; Ichihara H; Aoyama Y; Nishida S; Tsuboi A; Fujiki F; Tatsumi N; Nakajima H; Hino M; Kimura T; Yata K; Abe M; Oka Y; Oji Y; Kumanogoh A; Sugiyama H
Leukemia; 2012 Sep; 26(9):2135-41. PubMed ID: 22430638
[TBL] [Abstract][Full Text] [Related]
52. AL amyloidosis. Characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodies.
Perfetti V; Bellotti V; Garini P; Zorzoli I; Rovati B; Marinone MG; Ippoliti G; Merlini G
Lab Invest; 1994 Dec; 71(6):853-61. PubMed ID: 7807967
[TBL] [Abstract][Full Text] [Related]
53. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
[TBL] [Abstract][Full Text] [Related]
54. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis.
Leandro MJ; Cambridge G; Ehrenstein MR; Edwards JC
Arthritis Rheum; 2006 Feb; 54(2):613-20. PubMed ID: 16447239
[TBL] [Abstract][Full Text] [Related]
55. [The immunological phenotype and proliferative activity of the tumor lymphocytes in multiple myeloma].
Golenkov AK; Nazarova IN; Sarycheva TG; Miterev GIu; Kozinets GI
Ter Arkh; 1993; 65(7):38-41. PubMed ID: 8211777
[TBL] [Abstract][Full Text] [Related]
56. Application of flow cytometry immunophenotyping and multidrug resistance assay in B-cell acute lymphoid leukemia and multiple myeloma.
Jakab K; Gopcsa L; Adam E; Domjan G; Sarkadi B; Paloczi K
Neoplasma; 2005; 52(1):36-42. PubMed ID: 15739024
[TBL] [Abstract][Full Text] [Related]
57. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
[TBL] [Abstract][Full Text] [Related]
58. ZAP-70 expression is low in normal precursor B cells or hematogones.
Davis BH; Schwartz M
Cytometry B Clin Cytom; 2006 Jul; 70(4):315-9. PubMed ID: 16906572
[TBL] [Abstract][Full Text] [Related]
59. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells.
Georgantas RW; Tanadve V; Malehorn M; Heimfeld S; Chen C; Carr L; Martinez-Murillo F; Riggins G; Kowalski J; Civin CI
Cancer Res; 2004 Jul; 64(13):4434-41. PubMed ID: 15231652
[TBL] [Abstract][Full Text] [Related]
60. Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma.
Seegmiller AC; Xu Y; McKenna RW; Karandikar NJ
Am J Clin Pathol; 2007 Feb; 127(2):176-81. PubMed ID: 17210522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
